Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by 4Justiceon Apr 07, 2021 6:59pm
180 Views
Post# 32954219

ARMISTICE NOT BULLISH

ARMISTICE NOT BULLISHNEWCAMO...

LIMINAL filed an amended BLA last September with some responses to the FDA and implemented changes to manufacturing controls. The FDA postpone the PDUFA to July 5th because they needed more time to analyse and answer. These modifications have not been inspected by the FDA at the Laval plant. If they inspect in the comming weeks they could ask for new batch tests.

Consonnance threw the towel in December 2020. ARMISTICE the last major institutional invester, had 560 00 shares in December.

Have they sold? Do they still believe in your dream ? 
You will have the answer May 15 when they disclose their position at the SEC.


<< Previous
Bullboard Posts
Next >>